Hypertension is the leading risk factor for cardiovascular disease and premature death
among women globally. However, there is a fundamental lack of knowledge regarding the …

Disparities by race, gender, and other protected characteristics have been widely
documented in many important settings—such as employment, housing, criminal justice …

Background Significant race and sex disparities exist in the prevalence, diagnosis, and
outcomes of peripheral artery disease (PAD). However, clinical trials evaluating treatments …

We analyzed the inclusion of sex and/or gender (S/G) in Head and Neck Cancer (HNC)
clinical studies, through inspecting ClinicalTrials. gov (AACT) and the mention of Human …

A significant effort in biomedical sciences has been made to examine relationships between
sex and the mechanisms underlying various disease states and behaviors, including sleep …

Women are often underrepresented in clinical trials. It is unclear if this applies to trials in
kidney transplant (KT) and whether the intervention or trial focus influences this. In this study …

Due to hormonal variations, heart failure with preserved ejection fraction (HFpEF) remains
prevalent in women and affects almost half of the heart failure (HF) patients. Given the yearly …

The disconnection of neuronal circuitry through synaptic loss is presumed to be a major
driver of age‐related cognitive decline. Age‐related cognitive decline is heterogeneous, yet …

Historically, biomedical research has been led by and focused on men. The recent
introduction of Artificial Intelligence (AI) in this area has further proven this practice to be …

Patients with heart failure are conventionally stratified into phenotypic groups based on their
ejection fraction. The aim of this stratification is to improve disease management with a more …